Exact Mass: 520.2427546
Exact Mass Matches: 520.2427546
Found 268 metabolites which its exact mass value is equals to given mass value 520.2427546
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside]
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside] is a constituent of quince (Cydonia vulgaris) leaves
Purothionin AII
Isolated from wheat (Triticum monococcum). Toxic to brewers yeast. Purothionin AII is found in wheat, cereals and cereal products, and common wheat. Purothionin AII is found in cereals and cereal products. Purothionin AII is isolated from wheat (Triticum monococcum). Toxic to brewers yeast.
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
(6R,9R)-9-Hydroxy-4-megastigmen-3-one 9-O-??-D-glucopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
(1R,2R,3R,4R,5S,7R,9S,10R)-1-benzoyloxy-9-cinnamoyloxy-2,3-dihydroxydihydro-beta-agarofuran
1beta-benzoyl-8alpha-cinnamoyl-4alpha,5alpha-dihydroxydihydroagarofuran
3alpha,6alpha-dihydroxymegastigman-7-en-9-one 3-O-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|3alpha,6alpha-dihydroxymegastigman-7-en-9-one-3-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
2-(2,4,5-Trihydroxyphenyl)-3,6,8-tris(3-methyl-2-butenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one
3-hydroxy-5,6-epoxy-beta-ionol-3-O-beta-apiofuranosyl-(1->6)-beta-glucopyranoside
5R,6S,7E-megastigma-3-on-7-en-9-ol 9-O-beta-D-(6-O-beta-D-xylopyranosyl)glucopyranoside|ampelopsisionoside 6-O-beta-D-xylopyranoside|platanionoside C
5,7-Dihydroxy-6-methyl-2-phenyl-8-[1-(2-hydroxy-3,3,5,5-tetramethyl-4,6-dioxo-1-cyclohexenyl)-3-methylbutyl]-2H-1-benzopyran-4(3H)-one
13-hydroxyblumenol C apiosylglucoside|4-[3-(2-O-beta-apiofuranosyl-beta-glucopyranosyloxy)-butyl]-3-(hydroxymethyl)-5,5-dimethyl-2-cyclohexen-1-one
1-(3-Methoxy-4-hydroxyphenyl)-1-methoxy-2,3-bis(2-methoxy-4-allylphenoxy)propane
1b-Benzoyl-8a-cinnamoyl-4a,5a-dihydroxydihydroagarofuran
C24H40O12_(2R,3E)-4-[(1S,6R)-1-Hydroxy-2,2,6-trimethyl-4-oxocyclohexyl]-3-buten-2-yl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
quinidine gluconate
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C93038 - Cation Channel Blocker
Ala Phe Phe His
Ala Phe His Phe
Ala His Phe Phe
Cys Asp Lys Arg
Cys Asp Arg Lys
Cys Lys Asp Arg
Cys Lys Arg Asp
Cys Arg Asp Lys
Cys Arg Lys Asp
Asp Cys Lys Arg
Asp Cys Arg Lys
Asp His His Ile
C22H32N8O7 (520.2393841999999)
Asp His His Leu
C22H32N8O7 (520.2393841999999)
Asp His Ile His
C22H32N8O7 (520.2393841999999)
Asp His Leu His
C22H32N8O7 (520.2393841999999)
Asp Ile His His
C22H32N8O7 (520.2393841999999)
Asp Lys Cys Arg
Asp Lys Arg Cys
Asp Leu His His
C22H32N8O7 (520.2393841999999)
Asp Arg Cys Lys
Asp Arg Lys Cys
Glu His His Val
C22H32N8O7 (520.2393841999999)
Glu His Val His
C22H32N8O7 (520.2393841999999)
Glu Val His His
C22H32N8O7 (520.2393841999999)
Phe Ala Phe His
Phe Ala His Phe
Phe Phe Ala His
Phe Phe His Ala
Phe His Ala Phe
Phe His Phe Ala
Gly Lys Met Trp
Gly Lys Trp Met
Gly Met Lys Trp
Gly Met Trp Lys
Gly Trp Lys Met
Gly Trp Met Lys
His Ala Phe Phe
His Asp His Ile
C22H32N8O7 (520.2393841999999)
His Asp His Leu
C22H32N8O7 (520.2393841999999)
His Asp Ile His
C22H32N8O7 (520.2393841999999)
His Asp Leu His
C22H32N8O7 (520.2393841999999)
His Glu His Val
C22H32N8O7 (520.2393841999999)
His Glu Val His
C22H32N8O7 (520.2393841999999)
His Phe Ala Phe
His Phe Phe Ala
His His Asp Ile
C22H32N8O7 (520.2393841999999)
His His Asp Leu
C22H32N8O7 (520.2393841999999)
His His Glu Val
C22H32N8O7 (520.2393841999999)
His His Ile Asp
C22H32N8O7 (520.2393841999999)
His His Leu Asp
C22H32N8O7 (520.2393841999999)
His His Val Glu
C22H32N8O7 (520.2393841999999)
His Ile Asp His
C22H32N8O7 (520.2393841999999)
His Ile His Asp
C22H32N8O7 (520.2393841999999)
His Leu Asp His
C22H32N8O7 (520.2393841999999)
His Leu His Asp
C22H32N8O7 (520.2393841999999)
His Val Glu His
C22H32N8O7 (520.2393841999999)
His Val His Glu
C22H32N8O7 (520.2393841999999)
Ile Asp His His
C22H32N8O7 (520.2393841999999)
Ile His Asp His
C22H32N8O7 (520.2393841999999)
Ile His His Asp
C22H32N8O7 (520.2393841999999)
Lys Cys Asp Arg
Lys Cys Arg Asp
Lys Asp Cys Arg
Lys Asp Arg Cys
Lys Gly Met Trp
Lys Gly Trp Met
Lys Met Gly Trp
Lys Met Trp Gly
Lys Arg Cys Asp
Lys Arg Asp Cys
Lys Trp Gly Met
Lys Trp Met Gly
Leu Asp His His
C22H32N8O7 (520.2393841999999)
Leu His Asp His
C22H32N8O7 (520.2393841999999)
Leu His His Asp
C22H32N8O7 (520.2393841999999)
Met Gly Lys Trp
Met Gly Trp Lys
Met Lys Gly Trp
Met Lys Trp Gly
Met Asn Arg Thr
Met Asn Thr Arg
Met Gln Arg Ser
Met Gln Ser Arg
Met Arg Asn Thr
Met Arg Gln Ser
Met Arg Ser Gln
Met Arg Thr Asn
Met Ser Gln Arg
Met Ser Arg Gln
Met Thr Asn Arg
Met Thr Arg Asn
Met Trp Gly Lys
Met Trp Lys Gly
Asn Met Arg Thr
Asn Met Thr Arg
Asn Arg Met Thr
Asn Arg Thr Met
Asn Thr Met Arg
Asn Thr Arg Met
Gln Met Arg Ser
Gln Met Ser Arg
Gln Arg Met Ser
Gln Arg Ser Met
Gln Ser Met Arg
Gln Ser Arg Met
Arg Cys Asp Lys
Arg Cys Lys Asp
Arg Asp Cys Lys
Arg Asp Lys Cys
Arg Lys Cys Asp
Arg Lys Asp Cys
Arg Met Asn Thr
Arg Met Gln Ser
Arg Met Ser Gln
Arg Met Thr Asn
Arg Asn Met Thr
Arg Asn Thr Met
Arg Gln Met Ser
Arg Gln Ser Met
Arg Ser Met Gln
Arg Ser Gln Met
Arg Thr Met Asn
Arg Thr Asn Met
Ser Met Gln Arg
Ser Met Arg Gln
Ser Gln Met Arg
Ser Gln Arg Met
Ser Arg Met Gln
Ser Arg Gln Met
Thr Met Asn Arg
Thr Met Arg Asn
Thr Asn Met Arg
Thr Asn Arg Met
Thr Arg Met Asn
Thr Arg Asn Met
Val Glu His His
C22H32N8O7 (520.2393841999999)
Val His Glu His
C22H32N8O7 (520.2393841999999)
Val His His Glu
C22H32N8O7 (520.2393841999999)
Trp Gly Lys Met
Trp Gly Met Lys
Trp Lys Gly Met
Trp Lys Met Gly
Trp Met Gly Lys
Trp Met Lys Gly
(5Z,7E)-(1S,3R)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,25-triol
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside]
Blastmycin
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
26,26,26,27,27,27-hexafluoro-1alpha,25-dihydroxy-23,23,24,24-tetradehydrovitamin D3
C27H34O3F6 (520.2412006000001)
Duraquin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C93038 - Cation Channel Blocker
(2-Methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1-biphenyl]-4-yl)(1-methyl-6,7-dihydrospiro[furo[2,3-f]indole-3,4-piperidin]-5(2H)-yl)methanone
[(2R,3R,4S)-4-(1-benzothiophen-3-yl)-2-ethoxy-3-(3-hydroxypropyl)-3,4-dihydro-2H-pyran-6-yl]-[4-(phenylmethyl)-1-piperazinyl]methanone
(2S)-2-[(4S,5R)-5-[[benzyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2R)-2-[(4S,5R)-5-[[benzyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2S)-2-[(4S,5S)-5-[[benzyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2S)-2-[(4R,5S)-5-[[benzyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2R)-2-[(4R,5R)-5-[[benzyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2R)-2-[(4S,5S)-5-[[benzyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2S)-2-[(4R,5R)-5-[[benzyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2R)-2-[(4R,5S)-5-[[benzyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3,5-dimethyl-4-isoxazolesulfonamide
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1Z,4S,12R,14S,17Z)-12-hydroxy-19,19-dimethyl-7-(3-methylbut-2-enyl)-3,5,16,21-tetrazaheptacyclo[14.13.0.03,14.04,12.06,11.020,28.022,27]nonacosa-1(29),6,8,10,17,20(28),22,24,26-nonaene-2,15-dione
(1Z,4R,5S,14S,16S,19Z)-14-hydroxy-5,6,6,21,21-pentamethyl-3,7,18,23-tetrazaoctacyclo[16.13.0.03,16.04,7.04,14.08,13.022,30.024,29]hentriaconta-1(31),8,10,12,19,22(30),24,26,28-nonaene-2,17-dione
SB 224289
A member of the class of benzamides obtained by formal condensation of the carboxy group of 2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid with the secondary amino group of 1-methyl-6,7-dihydro-5H-spiro[furo[2,3-f]indole-3,4-piperidine]. Selective 5-HT1B receptor antagonist (pKi = 8.2). Displays >60-fold selectivity over 5-HT1D, 5-HT1A, 5-HT1E, 5-HT1F, 5-HT2A and 5-HT2C receptors in radioligand binding and functional assays. Centrally active following oral administration in vivo.
n-[(2r,3s,6s,7r,8r)-2,6-dimethyl-8-(3-methylbutyl)-7-[(2-methylpropanoyl)oxy]-4,9-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
5-(acetyloxy)-12-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
(1s,2r,5s,6s,7r,9r,12s)-7-(acetyloxy)-5-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-12-yl benzoate
(1s,2r,3r,4r,5r,6r,7s,9r)-3,4-dihydroxy-2,6,10,10-tetramethyl-7-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
n-[(2r,3s,6s,7r,8r)-7-(butanoyloxy)-2,6-dimethyl-8-(3-methylbutyl)-4,9-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
n-[7-(butanoyloxy)-2,6-dimethyl-8-(3-methylbutyl)-4,9-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
(4s)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one
3,4-dihydroxy-2,6,10,10-tetramethyl-7-[(3-phenylprop-2-enoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
4-(4-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-one
(1z,4s,12r,14r,17z)-12-hydroxy-19,19-dimethyl-5-(3-methylbut-2-en-1-yl)-3,5,16,21-tetraazaheptacyclo[14.13.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0²⁰,²⁸.0²²,²⁷]nonacosa-1(29),6,8,10,17,20(28),22,24,26-nonaene-2,15-dione
2-(2,6-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-6-(3-methylbut-2-en-1-yl)chromen-4-one
(6r,9r)-9-hydroxy-4-megastigmen-3-one 9-o-β-d-glucopyranosyl-(1→6)-β-d-glucopyrano-side
{"Ingredient_id": "HBIN012787","Ingredient_name": "(6r,9r)-9-hydroxy-4-megastigmen-3-one 9-o-\u03b2-d-glucopyranosyl-(1\u21926)-\u03b2-d-glucopyrano-side","Alias": "NA","Ingredient_formula": "C24H40O12","Ingredient_Smile": "CC(CCC1C=CC(=O)CC1(C)C)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10373","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}